Monday, January 12, 2009

Steel Partners Will Go Public to Avoid Additional Redemptions


Hedge fund plan splits opinion

By Steve Johnson

Published: January 12 2009 02:00 | Last updated: January 12 2009 02:00

Hedge fund investors are deeply divided on radical plans by Steel Partners, the activist hedge fund group run by Warren Lichtenstein, to convert its flagship fund into a listed industrial holding company, as revealed in the Financial Times on Saturday.

The New York-based group plans to transform its $1.2bn ($792m, €892m) Steel Partners II fund into a holding company spanning energy, aerospace, insurance and banking, likely to be listed on either Nasdaq or the New York stock exchange in the second quarter of 2009.

Steel Partners took the controversial step after facing an unprecedented wave of redemption requests; as of October it had received withdrawal notices for 38 per cent of the fund's assets.

"This is groundbreaking. It is definitely the most creative and radical solution we have come across," said Mike Vogel, partner at Elcot, a London-based family office with a "substantial" investment in the fund.

However, Gary Vaughan-Smith, partner at SilverStreet Capital, a fund of hedge funds that did not invest in Steel Partners, said: "This is good for the manager and bad for investors." Other hedge funds have reacted to large-scale redemption requests by imposing restrictions such as "gates", which limit the amount that can be withdrawn each month, or the creation of "sidepockets", new vehicles into which hard-to-sell assets are placed.

Steel Partners' solution trumps these options by effectively trapping capital within the fund, aside from a share buyback of up to $200m, or 17 per cent of its assets, upon listing.

Investors will only be able to sell shares in the market - possibly at a steep discount to net asset value - preventing capital from leaving the fund.

Steel Partners said in its letter to investors that it would be "impossible, inequitable and unfair [to remaining investors]" to accede to the redemption requests, given the fund has large, often controlling, stakes in its portfolio companies, rendering it "difficult, and in some instances impossible, to sell assets and businesses quickly".

As of September, just four holdings accounted for 50 per cent of the fund's assets, with eight positions accounting for 80 per cent of its assets.

"We believe this is by far and away the best and fairest solution for all investors. This transaction will give all investors the potential to buy/sell units in the public market at any time," said Steel Partners.

Mr Vogel argued: "It does, to us, look a pretty fair balance in terms of remaining investors and those who were looking to redeem; they will be able to go into a vehicle that has much enhanced liquidity. [Steel Partners] has recognised that this is a transformational change in terms of what is going on in the market and concentrated on what works in terms of getting value out."

But with the average single manager hedge fund listed on the London stock exchange, the major centre for such vehicles, currently trading on a discount of 23 per cent to NAV, Mr Vaughan-Smith said: "If the client wants to exit then a proper plan should be put in place to return the client's cash over time, rather than forcing them into structures which make them take an immediate hit."

One industry consultant feared the move, if replicated, could make it harder for the hedge fund industry to raise assets in future.

However some industry figures doubted the holding company concept would become commonplace, arguing that more short-term "trading" funds could fall foul of tax and regulatory issues in many jurisdictions.

After posting compound annual gross returns of 22 per cent a year from inception in 1990 to 2007, Steel Partners II fell 39 per cent last year, according to figures seen by the FT.

Saturday, January 10, 2009

NY City Bar to discuss activist shareholders


Counseling The Board of Directors in the Age of Activist Shareholders




Program Outline:

At this program, a panel of experts will discuss various issues and legal considerations that should be considered when counseling the Board of Directors of a public corporation, with particular attention given to how a Board should respond to demands for changes made by an activist shareholder. Panel discussions will provide an overview of the goals of activist investing and the tools employed by activists to accomplish them, as well as the latest strategies and defensive mechanisms used by public corporations to facilitate their interactions with activist investors. The program will also consider the duties and responsibilities of the Board when confronted with an activist investor and provide suggestions on how independent directors can do their job most effectively. Finally, an overview will be provided of the 2008/2009 proxy season.

Program Chair:

Jared Landaw

Senior Managing Director and General Counsel, Barington Capital Group, L.P.


Keynote Speakers:

Roel Campos

Former Commisioner of the SEC, Cooley Godward Kronish LLP

Martin Lipton

Wachtell, Lipton, Rosen & Katz


Faculty:

William D. Anderson, Jr.

Managing Director, Goldman, Sachs & Co.


Stephen L. Brown

Director, Corporate Governance

TIAA-CREF


Professor Charles M. Elson

Edgar S. Woolard, Jr., Chair & Director

John L. Weinberg Center for Corporate Governance

University of Delaware


Bruce H. Goldfarb

President & CEO, Okapi Partners


Phillip Goldstein

Principal and Co-Founder, Bulldog Investors


Keith E. Gottfried

Blank Rome LLP


David A. Katz

Wachtell, Lipton, Rosen & Katz


Roy J. Katzovicz

Chief Legal Officer, Pershing Square Capital Management


Michael J. Maimone

Greenberg Traurig LLP


Brian L. Schorr

Chief Legal Officer, Trian Fund Management LP


Steven A. Seiden

President, Seiden Krieger Associates


Daniel S. Sternberg

Cleary Gottlieb Steen & Hamilton LLP


Leo E. Strine, Jr

Vice Chancellor, Delaware Court of Chancery


Raymond S. Troubh

Director of Various Public Companies


Marc Weingarten

Schulte Roth & Zabel LLP


Christopher L. Young, JD, CFA

Director of M&A Research, RiskMetrics Group


When and Where:

On Tuesday, February 3, 2009 / 8:30a.m. to 12:45 p.m.

New York City Bar

42 West 44th Street, New York, NY 10036


Additional Information:

Call 212.382.6663

Register online


Thursday, January 8, 2009

Ron Burkle On A Buying Spree

Last week Ron Burkle, through his investment vehicle Yucaipa Companies, disclosed an 8.3% "active" ownership stake in Barnes & Noble, Inc. (BKS) and announced his belief that the shares are undervalued. His average cost is $14.68/share. We estimate 20% of BKS shares are held by activist investors; 25% is held by the Chairman/Founder.

Today Burkle announced he's spent about $100M to acquire a 7.0% stake in Whole Foods Market Inc. (WFMI) since November 24th at an average cost of $10.04/share.

Position: None

Activist Pressing Ahead At SUG Despite Redemptions

Activist investor Sandell Asset Management is forging ahead with their proxy contest to replace four directors at Southern Union Corp. (SUG) despite redemptions that have reduced their ownership stake in the Company.

On January 2nd Sandell distributed 1.3% of their ownership in SUG to their investors (who now control those votes). Sandell now owns 8.6% of the stock at an average cost of $29.07/share. SUG closed yesterday at $13.47.

On December 5th Sandell sent a letter to SUG announcing their intention to run a proxy contest in order to obtain four seats on the ten member board. Sandell believes the best course of action for SUG shareholders is an immediate sale of the Company.

Position: None

Tuesday, January 6, 2009

SRZ Issues a Client Alert on Selectica Activating their Poison Pill

Marc Weingarten (pictured here) and Nicholas Tomasetti from Schulte Roth & Zabel authored a Client Alert regarding Selectica's (SLTC) implementation of their posion pill.

In the Alert, the authors stated, "This represents a rare instance of a poison pill being triggered. Selectica's amended triggering threshold of 4.99% is extraordinarily low, with the norm generally being at a 15% or 20% level, and was adopted only after an activist investor surfaced. Whether the court accepts Selectica's purported justification for the low threshold of protecting NOLs will be a significant development, as other companies would be encouraged to find a basis to lower their pill thresholds as well."

Click here to view SRZ's full publication.

December's Activist Investments - 68 Companies Targeted



Below is a summary list of investments made by shareholder activists during December. This information was extracted from Hedge Fund Solutions' Catalyst Equity Research Report (TM), a free in-depth weekly research on activist investments.

Subscribe to the free report here.




Ticker Company Name Activist Investor
ACLS Axcelis Technologies Inc Sterling Capital
AEPI AEP Industries KSA Capital
ARS Arris Group Shamrock Activist Value fund
ATML Atmel Corp. Microchip Technology
AVGN Avigen Inc Biotechnology Value Fund
BCSB BCSB Bancorp Financial Edge Fund
BIOD Biodel Inc Moab Partners
CAMD California Micro Devices Corp Dialectic Capital Management
CKEC Carmike Cinemas Mark Cuban
CPWM Cost Plus Stephens Investment Management
CXX CombinatoRX, Incorporated Biotechnology Value Fund
CTO Consolidated Tomoka Land Co Wintergreen Advisers
DANKY Danka Business Systems PLC DCML LLC
DDS Dillard's Inc. Barington Capital; Clinton Group
DIN DineEquity Inc Southeastern Asset Management
DPS Dr Pepper Snapple Group Trian Fund
DUSA DUSA Pharmaceuticals SRB Management
DVD Dover Motorsports GAMCO
ESIO Electro Scientific Industries Nieremberg Investment Management
FIC Fair Isaac Corp Sandell Asset Management
FSFG First Savings Financial Group Joseph Stilwell
GGP General Growth Properties Pershing Square Capital
GLOB.OB Global Med Technologies Victory Park Capital
HIFN Hifn, Inc Adaptec, Inc
ICGN ICAgen, Inc Xmark Opportuntiy Partners
INFS InFocus Corp Nery Capital Partners
ITP Intertape Polymer Group KSA Capital Management
JAVA Sun Microsystems Southeastern Asset Management
JTX Jackson Hewitt Tax Service Shamrock
KANA.OB Kana Software KVO Capital Management
KFS Kingsway Financial Services Joseph Stilwell
KONA Kona Grill Mill Road Capital
LAQ The Latin America Equity Fund City of London Investment Management Co
LCAV LCA-Vision Inc. Stephen Joffe
MAG Magnetek Inc Riley Investment Management
MATH.PK Mathstar, Inc Salvatore Muoio; Zannet Opportunity Fund
MGAM Multimedia Games Dolphin Limited Partnership
MGLN Magellan Health Services Shamrock
MOVE Move Inc. Nierenberg Investmetn Management
MVCO Meadow Valley Corp Carpe Diem Capital
NDD Neuberger Berman Dividend Advantage Fund Western Investment
NTMD Nitromed Inc Deerfield Capital
OFIX Orthofix International Ramius Capital;
OPTV OpenTV Corp. Discovery Equity Partners
ORNG Orange 21 Costa Brava Partnership
PHMD PhotoMedex, Inc. James Sight
PIF Insured Municipal Income Fund Bulldog Investors
PPCO PenWest Pharmaceuticals Perceptive Advisors
PRXI Premier Exhibitions, Inc Sellers Capital
RDC Rowan Companies Steel Partners
RHIE RHI Entertainment Baupost Group
RIVR River Valley Bancorp Davee Thomas
SLRY Salary.com Cannell Capital
SLTC Selectica, Inc Versata
SUG Southern Union Co Sandell Asset Management
SUTM.OB Sun-Times Media Group Inc. K Capital
TIER Tier Technologies Inc Discovery Equity Partners
TLGD Tollgrade Communications Inc Bradford Capital
TMI TM Entertainment & Media Bulldog Investors
TRGL Toreador Resources Nanes Delorme Partners
TRMA Trico Marine Kistefos AS
TXCC TranSwitch Corp Brener International Group
TXI Texas Industries Southeastern Asset Management
WBSN Websense Inc Shamrock
WEDC White Electronic Designs Corp Wynnefield Capital
WOC Wilshire Enterprises Bulldog Investors
WRLS Telular Corp Simcoe Partners

Sunday, January 4, 2009

Selectica Inc. Pulls Trigger on Poison Pill

Selectica Inc. SLTC issued a press release on Saturday evening announcing that a Special Committee of the Board has ordered the exchange of each outstanding right under its Rights Agreement (aka the "Poison Pill"), as in effect as of the close of business on January 2, 2009, for one share of the Company’s common stock. Click here for the press release.

The exchange will double the number of shares of Selectica common stock owned by each stockholder of record as of the close of business on January 2, 2009, other than Versata Enterprises Inc., a subsidiary of Trilogy, Inc who has been accumulating stock above the Pill level.

Background
Activist investor Steel Partners owns 12.5% of SLTC.

On November 14th Versata Enterprises, a subsidiary of Trilogy, Inc., acquired 5.1% of the Company and made a verbal proposal to acquire the Company. (The details of the proposal have not yet been made public)

Reducing the Pill
On November 17th SLTC reduced the trigger on their poison pill from 15% to 4.99% purportedly to protect the value of their tax loss carry-forward benefits. (As of March 31st 2008 SLTC had federal and state net operating loss tax carry-forward assets equivalent to approximately $250M)

Ignoring the Pill
On December 18th and 19th Versata purchased an additional 154,051 shares of SLTC’s stock, bringing their ownership to 6.7%.

Triggering the Pill
On December 22nd Versata received a complaint (Selectica, Inc. vs. Versata Enterprises, Inc. and Trilogy, Inc., filed in the Court of Chancery of the State of Delaware on December 21, 2008) from Selectica seeking a declaratory judgment as to the validity of the Rights Agreement.

Selectica is currently trading around $0.88/share. As of October 31st 2008 the Company had $1.06/share in cash and short term investments.

Posted by Damien Park, Hedge Fund Solutions